RWB
BMY.RT

RMR Wealth Builders’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

RMR Wealth Builders’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Hold
0
– – – 218
2019
Q4 		$0 Buy
+37
New +$96 ﹤0.01% 419

Other funds holding BMY.RT

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

RMR Wealth Builders's BMY.RT Position: Q3 2020 in Review

RMR Wealth Builders held its Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) position steady in Q3 2020 at 0 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #218.

RMR Wealth Builders first reported a position in BMY.RT in Q4 2019 and has held it in 1 quarter since. The position peaked at $0 in Q4 2019. 571 funds tracked by Wall St. Rank hold BMY.RT as of Q3 2020.

  • RMR Wealth Builders held 0 shares of Bristol-Myers Squibb Company Contingent Value Rights worth $2K as of Q3 2020.
  • RMR Wealth Builders left its Bristol-Myers Squibb Company Contingent Value Rights share count unchanged in Q3 2020.
  • Bristol-Myers Squibb Company Contingent Value Rights made up ﹤0.01% of RMR Wealth Builders's portfolio in Q3 2020, its #218 holding.
  • RMR Wealth Builders first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and has held it in 1 quarter since.
  • RMR Wealth Builders's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $0 in Q4 2019.
  • 571 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q3 2020.

Based on RMR Wealth Builders's 13F filing for Q3 2020, filed 13 Nov 2020.